News
Sodium polystyrene sulfonate (SPS) has been commonly prescribed to treat hyperkalemia since its approval in 1959. Now new evidence published online ahead of print in JAMA Internal Medicine links ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback